France· FR:60880110
ALONEST 1,5 mg/mL, solution pour pulvérisation nasale
A medicinal product containing chlorhydrate d'azélastine, registered in France by VIATRIS MEDICAL, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'AZÉLASTINE
- Manufacturer
- VIATRIS MEDICAL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301855371 flacon(s) en verre brun de 20 ml avec pompe(s) doseuse(s) polypropylène polyéthylène polyoxyméthylène élastomère acier inoxydableEUR 6.22
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'azélastine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandAsteproCooper Consumer Health B.V.
- NetherlandsAstepro 1,5 mg/ml neusspray, oplossingCooper Consumer Health B.V.
- PolandAllergodil SPRINTCooper Consumer Health B.V.
- SpainASTEPRO 1,5 MG/ML SOLUCION PARA PULVERIZACION NASALCooper Consumer Health B.V.
- IrelandAstepro 1.5 mg/ml nasal spray, solutionCooper Consumer Health B.V.
- United StatesAstepro AllergyBayer HealthCare LLC.
- CzechiaALLERGODILCooper Consumer Health B.V., Diemen
- GermanyAllergo-AzelindDoppelherz Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Allergodil, Allergospray
- Belgium · Allergodil, Azelergo
- Bulgaria · Алергодил, Анталерг
- Czechia · Allergodil, Allergodil Forte
- Germany · Allergo-Azelind, Allergodil
- Denmark · Allergodil, Allergodil Forte
- Estonia · Allergodil
- Spain · Afluon, Afluón
- Finland · Lastin
- United Kingdom (Northern Ireland) · Astepro, Azelair
- Greece · Afluon
- Croatia · Vivialle, Vivispray
- Hungary · Allergodil, Allergodil Forte
- Ireland · Astepro, Azelastine Eye Drops Mylan Ire Healthcare
- Iceland · Astepro, Lastin
- Italy · Allergodil, Allespray
- Lithuania · Allergodil
- Luxembourg · Allergodil, Azelergo
- Latvia · Allergodil
- Malta · Antalerg Unimed Pharma, Azelastin-Comod
- Netherlands · Allergodil, Allergodil Nevel
- Norway · Lastin
- Poland · Acatar Allergy, Allergodil
- Portugal · Allergodil, Astepro
- Romania · Allegodil, Allergodil
- Sweden · Azelastine Omnivision
- Slovenia · Alezaxin, Allergodil
- Slovakia · Allergodil, Antalerg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7043d543-e870-44c6-9ea0-43c62627dfa4 GET /v1/drugs/7043d543-e870-44c6-9ea0-43c62627dfa4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60880110",
"date_amm": "2019-06-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE D'AZÉLASTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour pulvérisation",
"voies_administration": "nasale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'azélastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.